| # | Drug | Count |
|---|---|---|
| 0 | GANCICLOVIR | 2 |
| 1 | GANCICLOVIR SODIUM | 2 |
| 2 | INFLIXIMAB | 2 |
| 3 | PREDNISONE | 2 |
| 4 | RITUXIMAB | 2 |
| 5 | ERYTHROMYCIN | 1 |
| 6 | METHYLPREDNISOLONE | 1 |
| 7 | PRABOTULINUM TOXIN TYPE A | 1 |
| 8 | RUXOLITINIB | 1 |
| 9 | UPADACITINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRABOTULINUM TOXIN TYPE A | 1 | 0.0003 |
| 1 | GANCICLOVIR SODIUM | 2 | 0.0002 |
| 2 | ERYTHROMYCIN | 1 | 0.0001 |
| 3 | VALACYCLOVIR HYDROCHLORIDE | 1 | 0.0000 |
| 4 | RUXOLITINIB | 1 | 0.0000 |
| 5 | UPADACITINIB | 1 | 0.0000 |
| 6 | RITUXIMAB | 2 | 0.0000 |
| 7 | INFLIXIMAB | 2 | 0.0000 |
| 8 | METHYLPREDNISOLONE | 1 | 0.0000 |
| 9 | PREDNISONE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 2 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 3 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 6 | Corticosteroid [EPC] | 3 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 1 | 0.0000 |